Why the study?
Does pacemaker implantation provide clinical benefit for emerging indications such as neurally mediated syncope, hypertrophic obstructive cardiomyopathy, congestive heart failure, and prevention of atrial fibrillation?
Does pacemaker implantation provide clinical benefit for emerging indications such as neurally mediated syncope, hypertrophic obstructive cardiomyopathy, congestive heart failure, and prevention of atrial fibrillation?
This review summarizes the evidence for emerging indications for cardiac pacing beyond traditional sinus node dysfunction and heart block.
Provides synthesis of data on novel pacing indications; leaves open clinical adoption without further randomized evidence.
Substantial data have been accumulated and indications have been well delineated for pacemaker implantation in the treatment of sinus node dysfunction and heart block. However, many other indications have been proposed for pacemaker implantation. In this review, the authors examine available data regarding pacemaker implantation for new indications: neurally mediated syncope, hypertrophic obstructive cardiomyopathy, congestive heart failure, prevention of atrial fibrillation, and the relative merits of single-chamber and dual-chamber pacemakers.
No takes yet. Share an insight, caveat, or question.
Slotwiner et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: